GlassScriptPhysician profile
Elizabeth A Blair
NPI 1447808498
$2,596.48
in general payments reported to CMS, 2019-2025
31 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.09 · 2022: $14.45 · 2023: $403 · 2024: $987 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,439 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,438.94 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $338.33 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $253.01 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $225.65 | 2023-2025 | Veozah |
| Abbvie INC. | $182.06 | 2025 | |
| Glaxosmithkline, LLC. | $180.29 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $169.33 | 2023-2025 | Repatha, Repatha, Otezla |
| Lilly USA, LLC | $166.57 | 2023-2025 | Mounjaro, Zepbound, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.72 | 2024-2025 | Jardiance |
| Exact Sciences Corporation | $100.81 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $90.40 | 2023-2025 | |
| Corcept Therapeutics | $82.56 | 2025 | Korlym |
| Dexcom, INC. | $81.05 | 2023-2025 | Dexcom G6 Transmitter |
| Dynavax Technologies Corporation | $75.01 | 2024-2025 | Heplisav-B |
| Vivus LLC | $70.41 | 2023-2024 | Qsymia |
| Sanofi-Aventis U.S. LLC | $48.25 | 2024-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $44.29 | 2024 | Inspire |
| Seqirus USA INC | $43.91 | 2024 | Fluad, Flucelvax |
| Phathom Pharmaceuticals, INC. | $39.45 | 2024 | Voquezna |
| Hikma Pharmaceuticals USA | $37.69 | 2023-2024 | Ryaltris |
| Merck Sharp & Dohme LLC | $37.49 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Lundbeck LLC | $37.44 | 2025 | Vyepti |
| Soleno Therapeutics, INC. | $27.12 | 2025 | Vykat Xr |
| Antares Pharma, INC. | $21.01 | 2025 | Xyosted |
| Tris Pharma INC | $18.39 | 2025 | Dyanavel Xr |
| Novartis Pharmaceuticals Corporation | $17.71 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $17.32 | 2023 | Livalo |
| Currax Pharmaceuticals LLC | $15.69 | 2025 | Contrave |
| Aimmune Therapeutics, INC. | $15.58 | 2024 | |
| Gilead Sciences, INC. | $14.90 | 2021 | |
| Boston Scientific Corporation | $14.45 | 2022 | |
| Avvisto Therapeutics, LLC | $13.59 | 2025 | Cycloset |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Blair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.